Abstract 4370214: Atrial 18F-Fludeoxyglucose Avidity is Higher in Persistent than Paroxysmal Atrial Fibrillation

R Romanos Haykal (University of Washington, Seattle, Washington, United States) A Ahmad Kassar (University of Washington, Seattle, Washington, United States) N Nadia Chamoun (University of Washington, Seattle, Washington, United States) Y Yaacoub Chahine (University of Washington, Seattle, Washington, United States) T Tori Hensley (University of Washington, Seattle, Washington, United States) H Hala Al Yasiri (Uniersity of washington, Auburn, Washington, United States) E Efstathia Andrikopoulou (Harborview Medical Center, Seattle, Washington, United States) M Murat Sadic (University of Washington, Seattle, Washington, United States) N Nazem Akoum (University of Washington, Seattle, Washington, United States)

Abstract

Background: Atrial fibrillation (AF) is marked by underlying inflammation and metabolic changes. Atrial 18F-Fludeoxyglucose (FDG) positron emission tomography (PET) can be used to assess these changes. Previous studies show increased FDG avidity in AF. Aim: We aim to investigate atrial uptake differences between paroxysmal AF (pAF) and persistent AF (perAF). Hypothesis: Patients with perAF exhibit a greater atrial FDG-PET avidity and demonstrate higher quantitative uptake measures compared to those with pAF. Methods: Patients undergoing FDG-PET for the evaluation of cardiac sarcoidosis (CS) were assessed for atrial avidity. Atrial FDG uptake, a semi-quantitative measure, was quantified using standardized uptake value (SUV)-mean, SUV-max, and normalized to the blood pool as the target-to-background ratio (TBR). Qualitatively, intensity with respect to liver uptake (less vs equal or greater), pattern (focal vs diffuse), and location were reported. AF types were determined using patient’s electronic medical records. Results: One hundred and twenty-six patients (age 67 ± 12 years, 26% female, BMI 29.8 ± 6.5 kg/m2) were included in the study. 35 pts (27.4%) met diagnostic criteria for cardiac sarcoidosis (CS). 79 (62.7%) patients had pAF, 39 (31%) had perAF, 8 (6.3%) had an unspecified subtype. Atrial avidity was seen in 45 patients and distributed accordingly: 30 in the right atrium, 13 bi-atrial, and 2 left atrial. Avidity had a predominant diffuse pattern (66.7%) with intensity equal or greater than the liver’s (62%). 23 (58%) of the avid atria were in perAF patients while only 22 (38%) were in pAF patients. Quantitively, aTBRmax was significantly higher in perAF group (1.35 ± 0.51 vs 1.14 ± 0.39, p=0.03). PerAF was associated with a higher aTBRmax (B=0.2, CI 0.03-0.37, p=0.02) after adjusting for cardiac sarcoidosis. Conclusion: Persistent AF is associated with higher qualitative and quantitative atrial FDG-PET avidity compared to paroxysmal AF. Additional studies are needed to better understand causality and mechanisms behind these associations.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (9)

R

Romanos Haykal

University of Washington, Seattle, Washington, United States

A

Ahmad Kassar

University of Washington, Seattle, Washington, United States

N

Nadia Chamoun

University of Washington, Seattle, Washington, United States

Y

Yaacoub Chahine

University of Washington, Seattle, Washington, United States

T

Tori Hensley

University of Washington, Seattle, Washington, United States

H

Hala Al Yasiri

Uniersity of washington, Auburn, Washington, United States

E

Efstathia Andrikopoulou

Harborview Medical Center, Seattle, Washington, United States

M

Murat Sadic

University of Washington, Seattle, Washington, United States

N

Nazem Akoum

University of Washington, Seattle, Washington, United States